Impairment of mitochondrial respiration in platelets and placentas: a pilot study in preeclamptic pregnancies

Anca M Bînă1,2, Oana M Aburel1,2, Vlad F Avram2,3

  • 1Department III Functional Sciences - Pathophysiology, "Victor Babeş" University of Medicine and Pharmacy, Timişoara, Romania, Eftimie Murgu Sq. No. 2, Timişoara, Romania.

Insights

Preeclampsia impacts platelet and placental mitochondria differently. Platelet respiration decreases, while placental mitochondria show varied responses based on fetal growth, suggesting complex adaptive mechanisms.

Area of Science:

  • Obstetrics and Gynecology
  • Mitochondrial Biology
  • Pathophysiology

Background:

  • Preeclampsia (PE) is a pregnancy complication with unclear causes.
  • Placental mitochondrial dysfunction is a key suspected mechanism in PE.
  • Platelet mitochondrial respiration may serve as a biomarker for organ dysfunction.

Purpose of the Study:

  • To investigate mitochondrial respiratory function in platelets and placental mitochondria in preeclampsia.
  • To compare mitochondrial function between preeclamptic and healthy pregnancies.
  • To explore the relationship between placental mitochondrial function and fetal birth weight in PE.

Main Methods:

  • High-resolution respirometry using a SUIT protocol.
  • Assessment of complex I and complex II supported respiration.
  • Comparison of respiratory parameters in platelets and placental mitochondria.

Main Results:

  • Preeclamptic pregnancies showed decreased respiratory parameters in peripheral platelets compared to controls.
  • Placental mitochondria exhibited dichotomous respiratory behavior in PE.
  • PE with fetal growth restriction showed decreased placental oxidative phosphorylation and electron transfer capacity.
  • PE with normal weight fetuses showed increased placental complex I and II supported respiration.

Conclusions:

  • Platelet mitochondrial dysfunction is a potential biomarker for preeclampsia.
  • Placental mitochondrial function in PE is complex and influenced by fetal growth.
  • Further research with large clinical studies is needed to understand adaptive vs. pathological mitochondrial changes in PE.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.2K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
43